Loading...
XLON
IDHC
Market cap392mUSD
Dec 05, Last price  
0.68USD
1D
-0.74%
1Q
41.81%
Jan 2017
-19.94%
IPO
-53.45%
Name

Integrated Diagnostics Holdings PLC

Chart & Performance

D1W1MN
XLON:IDHC chart
P/E
17.30
P/S
3.26
EPS
1.85
Div Yield, %
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
20.77%
Revenues
5.72b
+38.74%
641,595,747671,583,450860,231,4311,014,844,0001,170,621,0001,514,257,0001,921,452,0002,226,495,0002,656,264,0005,224,712,0003,605,047,0004,122,506,0005,719,742,000
Net income
1.08b
+111.14%
24,641,81162,095,022132,768,888144,873,000260,399,000374,023,000502,092,000510,931,000594,015,0001,412,609,000541,110,000510,304,0001,077,434,000
CFO
1.57b
+188.52%
639,095,868209,290,684301,587,025189,862,000398,658,000403,075,000556,308,000697,414,000882,515,0002,269,845,000208,729,000543,663,0001,568,602,000
Dividend
Jun 16, 20220.116 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
IPO date
May 06, 2015
Employees
6,718
Domiciled in
JE
Incorporated in
JE

Valuation

Title
EGP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT